The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 22, 2020

Filed:

Jun. 15, 2016
Applicants:

Merck Patent Gmbh, Darmstadt, DE;

Pfizer Inc., New York, NY (US);

Inventors:

Glen Ian Andrews, San Diego, CA (US);

Shihao Chen, Foster City, CA (US);

Alessandra Di Pietro, Opera, IT;

David Fontana, Clyde Hill, WA (US);

Zelanna Goldberg, San Diego, CA (US);

Chia-Yang Lin, Palo Alto, CA (US);

Hua Long, San Carlos, CA (US);

Marcella Martignoni, Milan, IT;

Dimitry Serge Antoine Nuyten, San Francisco, CA (US);

Aron David Thall, San Diego, CA (US);

Adrian Woolfson, New York, NY (US);

Assignees:

MERCK PATENT GMBH, Darmstadt, DE;

PFIZER INC., New York, NY (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/00 (2006.01); A61K 39/395 (2006.01); A61K 31/4439 (2006.01); C07K 16/24 (2006.01); C07K 16/28 (2006.01); A61K 45/06 (2006.01); A61P 35/00 (2006.01); A61K 31/4184 (2006.01); A61K 31/706 (2006.01); A61K 33/24 (2019.01);
U.S. Cl.
CPC ...
A61K 39/3955 (2013.01); A61K 31/4184 (2013.01); A61K 31/4439 (2013.01); A61K 31/706 (2013.01); A61K 33/24 (2013.01); A61K 39/39558 (2013.01); A61K 45/06 (2013.01); A61P 35/00 (2018.01); C07K 16/243 (2013.01); C07K 16/2827 (2013.01); C07K 16/2878 (2013.01); C07K 16/2887 (2013.01); A61K 2039/505 (2013.01); A61K 2039/507 (2013.01); C07K 2317/21 (2013.01); C07K 2317/76 (2013.01);
Abstract

The present disclosure describes combination therapies comprising an antagonist of Programmed Death Ligand 1 receptor (PD-L1) and another therapeutic agent, and the use of the combination therapies for the treatment of cancer.


Find Patent Forward Citations

Loading…